Press "Enter" to skip to content

Posts published in “UCLA”

UCLA Clinical Trial Shows Promise for Treating Some Metastatic Breast Cancers

LOS ANGELES—There is a promising new drug in the arsenal of doctors treating women with HER2 positive metastatic breast cancer, according to results of a study at the UCLA Jonsson Comprehensive Cancer Center released on Sept. 18. The HER2-targeting antibody drug conjugate trastuzumab deruxtecan (T-DXd) significantly prolongs the length of time the disease is controlled […]